FILE PHOTO: View of Catalent’s drug product manufacturing laboratory in

FILE PHOTO: A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman/File Photo